Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1983-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.80.8.2276PMID 6300905PMCID PMC393802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.

  1982cited by this paper
• Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture

  1982cited by this paper
• Internalized insulin receptors are recycled to the cell surface in rat hepatocytes.

  1982cited by this paper
• Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts.

  1982cited by this paper
• Proteolytic cleavage of epidermal growth factor receptor. A Ca2+-dependent, sulfhydryl-sensitive proteolytic system in A431 cells.

  1982cited by this paper
• Epidermal growth factor carrier protein binds to cells via a complex with released carried protein nexin.

  1982cited by this paper
• Acetylcholine receptor: effects of proteolysis on receptor metabolism

  1982cited by this paper
• Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.

  1981cited by this paper
• Evidence for membrane association of plasminogen activator activity in mouse macrophages.

  1980cited by this paper
• Studies on the control of plasminogen activator production by cultured human embryonic lung cells: Requirements for inhibition by corticosteroids

  1980cited by this paper
• Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator.

  1979cited by this paper
• Experiments with normal and transformed cells : a laboratory manual for working with cells in culture

  1978cited by this paper
• Metabolism of acetylcholine receptor in chick embryo muscle cells: effects of RSV and PMA.

  1978cited by this paper
• Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.

  1978cited by this paper
• Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells.

  1978cited by this paper
• Human epidermal growth factor and the proliferation of human fibroblasts

  1976cited by this paper
• Membrane receptors and hormone action.

  1976cited by this paper
• Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells

  1976cited by this paper
• 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts

  1976cited by this paper
• Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

  1972cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• An enzymic method for the trace iodination of immunoglobulins and other proteins.

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling

  2022cites this paper
• Cellular and Molecular Mechanisms of Retinal Angiogenesis

  2008cites this paper
• Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A.

  2005cites this paper
• Regulation and interactions in the activation of cell-associated plasminogen

  2004cites this paper
• Regulation of Plasminogen Activation HELI

  2003cites this paper
• Regulation of plasminogen activation

  2003cites this paper
• Elimination of Hydrocortisone from the Medium Enables Tissue Plasminogen Activator Gene Expression by Normal and Immortalized Nonmalignant Human Epithelial Cells

  2001cites this paper
• The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain

  2001cites this paper
• Cultivation and transplantation of epidermal keratinocytes.

  1999cites this paper
• Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).

  1998cites this paper
• Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.

  1998cites this paper
• TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells.

  1996cites this paper
• Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).

  1996cites this paper
• Regulation of the plasminogen activator/plasmin system by epidermal growth factor in cultured human endometrial cells.

  1995cites this paper
• Differential recovery of macrophages from endotoxin-tolerant states elicited by lipopolysaccharide and enzymatic treatments.

  1994cites this paper
• Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

  1994cites this paper
• New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.

  1993cites this paper
• Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.

  1993cites this paper
• Different induction pathways for urokinase (u-PA) in A431 cells by EGF and by the phorbol ester, TPA

  1993cites this paper
• The plasminogen activator/plasmin system.

  1991cites this paper
• Immortalizing genes of Epstein-Barr virus.

  1991cites this paper
• Epidermal Growth Factor and 12-Tetradecanoyl Phorbol 13-Acetate Induction of Urokinase in A431 Cells

  1991cites this paper
• Regulation of human tissue-type plasminogen activator gene transcription by epidermal growth factor and 3',5'-cyclic adenosine monophosphate.

  1991cites this paper
• The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover.

  1991cites this paper
• Regulation of the truncation of luteinizing hormone receptors at the plasma membrane is different in rat and mouse Leydig cells.

  1991cites this paper
• The epidermal growth factor receptor and the prognosis of bladder cancer

  1990cites this paper
• [Epidermal growth factor receptor (EGF-R) in human breast cancer--a marker of morphologic-functional differentiation].

  1990cites this paper
• Concomitant Secretion by A431 Cells of Tissue Plasminogen Activator and a Specific Inhibitor Masks EGF Modulation of tPA Activity

  1990cites this paper
• Epidermal Growth Factor Prolongs Survival Time of Tumor‐bearing Mice

  1990cites this paper
• Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer

  1990cites this paper
• Epidermal growth factor receptor expression in demented and aged human brain.

  1990cites this paper
• Down-regulation of mannose receptor activity in macrophages after treatment with lipopolysaccharide and phorbol esters.

  1990cites this paper
• Alveolar epithelial cell plasminogen activator. Characterization and regulation.

  1990cites this paper
• Epidermal growth factor stimulates the anchorage-independent growth of human squamous cell carcinomas overexpressing its receptors.

  1990cites this paper
• Absence of specific cell-surface binding of tissue plasminogen activator in uterine cells.

  1990cites this paper
• Induction of Proteases and Protease Inhibitors by Growth Factors

  1990cites this paper
• Urokinase receptors in lung cancer and normal lung.

  1990cites this paper
• Rapid degradation of extracellular matrix proteins by normal human uroepithelial cells.

  1990cites this paper
• Growth Factor Biology and Oncogene Activation in Human Gliomas and Their Implications for Specific Therapeutic Concepts

  1989cites this paper
• In vitro membrane desialylation in porcine granulosa cells unmasks functional receptors for follicle-stimulating hormone.

  1989cites this paper
• Epidennal Growth Factor Receptor in Human Breast Cancer

  1989cites this paper
• Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562).

  1989cites this paper
• Epidermal growth factor stimulates tissue plasminogen activator activity and messenger ribonucleic acid levels in cultured rat granulosa cells: mediation by pathways independent of protein kinases-A and -C.

  1989cites this paper
• Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.

  1989cites this paper
• A comparison of the effect of several factors on the plasminogen activator activity of cloned lines from an ethylnitrosourea-induced glioma and from normal tissue.

  1989cites this paper
• Endocrine Therapy and Growth Regulation of Breast Cancer

  1989cites this paper
• Epidermal growth factor receptor in human breast cancer.

  1989cites this paper
• Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors.

  1988cites this paper
• Localization of human malignant tumors with radioiodinated recombinant tissue plasminogen activator.

  1988cites this paper
• Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line

  1988influential citation
• Epidermal growth factor receptors in human breast cancer.

  1988cites this paper
• Cell-associated plasminogen activation: regulation and physiological functions.

  1988cites this paper
• Astrocyte mitogen inhibitor related to epidermal growth factor receptor.

  1988cites this paper
• Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta

  1988cites this paper
• Secretion of plasminogen activators by human colorectal and gastric tumor explants

  1988cites this paper
• Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium.

  1988cites this paper
• The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

  1988cites this paper
• Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

  1988cites this paper
• Induction of urokinase-type plasminogen activator by UV light in human fetal fibroblasts is mediated through a UV-induced secreted protein

  1987cites this paper
• Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

  1987cites this paper
• Hormonal and immunological characterization of the cell-associated plasminogen activators produced by cultured rat granulosa cells.

  1987cites this paper
• Aprotinin antagonizes the binding of human chorionic gonadotropin to its receptor.

  1987cites this paper
• Binding of tissue plasminogen activator to cultured human endothelial cells.

  1987cites this paper
• Tissue plasminogen activators in breast cancer.

  1987cites this paper
• Proteolytic degradation of extracellular matrix in tumor invasion.

  1987cites this paper
• Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity

  1987cites this paper
• Urokinase: the Enzyme Responsible for Invasion and Metastasis in Human Breast Carcinoma?

  1987cites this paper
• Interaction of Mammary Tumor Subpopulations

  1987cites this paper
• Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate

  1986cites this paper
• Responses of Metastatic Rhabdomyosarcoma Cells and Normal Myoblasts to Growth Factors Derived from Normal Tissues

  1986cites this paper
• Proteolytic Enzymes in Tumor Invasion and Degradation of Host Extracellular Matrices

  1986cites this paper
• Electrophoretic analysis of membrane proteases in the luteinized rat ovary.

  1986cites this paper
• Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29).

  1986cites this paper
• Efficient synthesis of human type alpha transforming growth factor: its physical and biological characterization.

  1986cites this paper
• The Mr 17500 region of the A chain of urokinase is required for interaction with a specific receptor in A431 cells.

  1986cites this paper
• Gene expression during the mammalian cell cycle.

  1986cites this paper
• Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

  1986cites this paper
• Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.

  1986cites this paper
• Regulation of protein breakdown by epidermal growth factor in A431 cells.

  1985cites this paper
• DNA repair: relationship to drug and radiation resistance, metastasis and growth factors.

  1985cites this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cites this paper
• Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer.

  1985cites this paper
• Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth.

  1985cites this paper
• Plasminogen activation and regulation of pericellular proteolysis.

  1985cites this paper
• Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.

  1985cites this paper
• Involvement of plasma membrane enzymes in the proteolytic cleavage of luteinizing hormone receptor.

  1985cites this paper
• Plasminogen activator: Morphological evidence of binding, internalization and delivery to lysosomes in 3T3 mouse fibroblasts

  1985cites this paper
• Epidermal growth factor receptors on human breast cancers

  1985cites this paper
• DNA repair and resistance to chemotherapy.

  1985cites this paper
• Thyrotropin regulation of plasminogen activator activity in primary cultures of ovine thyroid cells.

  1984cites this paper
• Production of an epidermal growth factor receptor-related protein.

  1984cites this paper
• Agonist-specific desensitization of shape change of platelets.

  1984cites this paper
• Yuji Saitoli Teruaki &nada? Hiroshi ShimadaIi Takashi Kikuchili

  1984cites this paper
• Transcriptional induction of urokinase in cultured human kidney carcinoma cells by tetradecanoyl‐phorbol‐acetate

  1984cites this paper
• [Epidermal growth factor: structure, location, phosphorylation and regulation of its receptor].

  1984cites this paper
• The cell surface in health and disease.

  1984cites this paper
• Diminished in vitro tyrosine kinase activity of the EGF receptor of senescent human fibroblasts

  1983cites this paper
• Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.

  1983cites this paper
• Regulation of the insulin receptor by a monoclonal anti-receptor antibody. Evidence that receptor down regulation can be independent of insulin action.

  1983cites this paper